|Title||Erratum to “Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary|
|Publication Type||Journal Article|
|Year of Publication||2017|
|Authors||Vogelmeier, CF, Criner, GJ, Martinez, FJ, Anzueto, A, Barnes, PJ, Bourbeau, J, Celli, BR, Chen, R, Decramer, M, Fabbri, LM, Frith, P, Halpin, DM, Varela, MVLópez, Nishimura, M, Roche, N, Rodríguez-Roisin, R, Sin, D, Singh, D, Stockley, R, Vestbo, J, Wedzicha, JA, Agusti, A|
|Journal||Archivos de Bronconeumolgia|
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.